"/> Novus Biologicals™ Peptide bloquant d’anticorps MT… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps MTA2

Réf. : BL-RE-081906Réf. fabricant : 18250656 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
9219
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76748. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 17 amino acids of human MTA2.

Points forts

Source

Synthetic

(Accession #: AAG02241) The MTA2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-081906
Réf. fabricant18250656
Gene ID (Entrez)9219
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76748. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDKFZp686F2281, metastasis associated 1 family, member 2, metastasis -associated gene 1-like 1, metastasis associated gene family, member 2, Metastasis-associated 1-like 1, metastasis-associated protein 2, metastasis-associated protein MTA2, MTA1-L1 protein, MTA1L1MTA1-L1, p53 target protein in deacetylase complex, PID
Symbole de gène(s)MTA2
Type de produitMTA2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne17 amino acids of human PID
Une question, une configuration particulière ?
Contactez-nous pour un devis.